{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Art+Therapy&page=7", "query": { "condition": "Art Therapy", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 567, "total_pages": 57, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Art+Therapy&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Art+Therapy&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T09:53:06.684Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02478632", "title": "Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Subjects do not receive study medication in this study 202094", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 102, "start_date": "2015-06-12", "completion_date": "2018-08-17", "has_results": true, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 7, "location_summary": "Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02478632" }, { "nct_id": "NCT02329782", "title": "Supporting Treatment Adherence Readiness Through Training (START)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Medication Adherence" ], "interventions": [ { "name": "Adherence Readiness Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "RAND", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2015-02", "completion_date": "2020-03-30", "has_results": false, "last_update_posted_date": "2020-10-06", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 3, "location_summary": "Long Beach, California • Los Angeles, California", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02329782" }, { "nct_id": "NCT01928927", "title": "Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV-1 Infection" ], "interventions": [ { "name": "Telmisartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2014-01", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2021-08-03", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 11, "location_summary": "Los Angeles, California • Aurora, Colorado • Boston, Massachusetts + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01928927" }, { "nct_id": "NCT02245308", "title": "Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tobacco Use Disorder", "Homelessness" ], "interventions": [ { "name": "Nicotine Patches", "type": "DRUG" }, { "name": "mobile contingency management (mCM)", "type": "BEHAVIORAL" }, { "name": "Smoking cessation counseling", "type": "BEHAVIORAL" }, { "name": "Nicotine rescue method", "type": "DRUG" }, { "name": "Bupropion", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 133, "start_date": "2014-10-01", "completion_date": "2018-09-28", "has_results": true, "last_update_posted_date": "2022-01-04", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02245308" }, { "nct_id": "NCT04039217", "title": "Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "ART", "HIV" ], "interventions": [ { "name": "Biktarvy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "MALE", "summary": "18 Years to 49 Years · Male only" }, "enrollment_count": 20, "start_date": "2019-09-30", "completion_date": "2020-08-28", "has_results": true, "last_update_posted_date": "2022-02-22", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04039217" }, { "nct_id": "NCT06280976", "title": "Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Atherosclerosis", "Heart Attack" ], "interventions": [ { "name": "Statin", "type": "DRUG" }, { "name": "Aspirin tablet", "type": "DRUG" }, { "name": "Nexlizet", "type": "DRUG" }, { "name": "LEQVIO", "type": "DRUG" }, { "name": "Vascepa", "type": "DRUG" }, { "name": "Jardiance", "type": "DRUG" }, { "name": "Colchicine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Louisville", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2024-03-01", "completion_date": "2025-01-01", "has_results": false, "last_update_posted_date": "2025-03-17", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT06280976" }, { "nct_id": "NCT00039663", "title": "Endothelial Dysfunction as a Risk Factor in HIV Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Pravastatin", "type": "DRUG" }, { "name": "Gemfibrozil", "type": "DRUG" }, { "name": "Rosiglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 75, "start_date": "2002-05", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00039663" }, { "nct_id": "NCT01969409", "title": "Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ambulatory IPF" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 58, "start_date": "2014-01", "completion_date": "2020-11-30", "has_results": true, "last_update_posted_date": "2024-08-21", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 7, "location_summary": "Birmingham, Alabama • Boston, Massachusetts • Minneapolis, Minnesota + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Danville", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01969409" }, { "nct_id": "NCT04776304", "title": "Art Therapy QEEG Study for Service Members with a Traumatic Brain Injury and Posttraumatic Stress Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-Traumatic Headache", "PTSD", "TBI", "TBI (Traumatic Brain Injury)", "MTBI - Mild Traumatic Brain Injury", "Posttraumatic Stress Disorder", "Posttraumatic Stress Disorder, Delayed Onset", "Sleep Disturbance", "Nightmare", "Nightmares, REM-Sleep Type", "Headache", "Irritable Mood", "Anger", "Eating Disorders", "Combat and Operational Stress Reaction", "Combat Stress Disorders", "Military Operations", "Military Activity", "Military Family" ], "interventions": [ { "name": "Art Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Walter Reed National Military Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 2, "start_date": "2021-10-30", "completion_date": "2024-01-25", "has_results": false, "last_update_posted_date": "2024-11-06", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04776304" }, { "nct_id": "NCT05398185", "title": "WiseApp for Spanish Speakers Living With HIV", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections", "Acquired Immune Deficiency Syndrome", "Sexually Transmitted Diseases, Viral" ], "interventions": [ { "name": "CleverCap", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 241, "start_date": "2023-03-01", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-08T09:53:06.684Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05398185" } ] }